Anaphylaxis complicating routine childhood immunization: Hemophilus influenza b conjugated vaccine

Pediatric Asthma, Allergy and Immunology

Volumn 14, Issue 4, 2000, Pages 315-321

  Nelson, M R ^a,b   Oaks, H ^c   Smith, L J ^a,b   Engler, R J M ^a,b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b Uniformed Services University of the Health Sciences   (United States)

^c WOMACK ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE; PNEUMOCOCCUS VACCINE;

ANAPHYLAXIS; ARTICLE; CASE REPORT; CROSS REACTION; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; INFANT; INFECTION PREVENTION; INFLUENZA; MALE; PRIORITY JOURNAL; RASH; VACCINATION;

EID: 0034472848     PISSN: 08831874     EISSN: None     Source Type: Journal    
DOI: 10.1089/088318700750070411     Document Type: Article

References (16)

1. American Academy of Pediatrics. Active and passive immunization
2. American Academy of Pediatrics. Active and passive immunization
3. American Academy of Pediatrics. Summaries of infectious diseases
4. Anaphylaxis to measles, mumps, and rubella vaccine mediated by IgE to gelatin
5. Egg hypersensitivity and adverse reactions to measles, mumps, and rubella vaccine
6. Drug and vaccine allergy
7. Severe hypersensitivity or intolerance reactions to measles vaccine in six children: Clinical and immunologic studies
8. Safe administration of the measles vaccine to children allergic to eggs
9. Drug allergy
10. Drug allergy and protocols for management of drug allergies
11. Recommendations for use of Haemophilus b conjugate vaccines and a combined diphtheria, tetanus, pertussis, and Haemophilus b vaccine
12. Progress toward eliminating Haemophilus influenzae type b disease among infants and children - United States, 1987-97
13. Adverse reactions reported following receipt of Haemophilus influenza type b vaccine: An analysis after one year of marketing
14. Acute urticaria and angio-oedema following Haemophilus influenzae b vaccination
15. Policy statement: Recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis
16. 197 in United States infants